Bilbe; Graeme

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bilbe; Graeme.The latest application filed is for "use of s1p receptor modulator".

Company Profile

0.4.13

Bilbe; Graeme - Neuchatel N/A CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-et- hyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndrome Grant 9,265,754 - Barde , et al. February 23, 2	2016-02-23
Use Of S1p Receptor Modulator App 20140011884 - BARDE; Yves-Alain ; et al.	2014-01-09
Use Of S1p Receptor Modulator App 20120245129 - Barde; Yves-Alain ; et al.	2012-09-27
Combinations For The Treatment Of Migraine App 20110212980 - Bilbe; Graeme ; et al.	2011-09-01
Combinations Of Nicotinic Acetylcholine Alpha 7 Receptor Agonists App 20100125063 - KALKMAN; Hans O. ; et al.	2010-05-20
Use Of S1p Receptor Modulator App 20100093672 - Barde; Yves-Alain ; et al.	2010-04-15
Use of pyridinyl-pyrimidinylamino-benzamide derivatives for the treatment of amyloid related disorders Grant 7,687,512 - Bilbe March 30, 2	2010-03-30
Use Of S-10-hydroxy-10,11-dihydro-carbamazepine For The Treatment Of Anxiety And Bipolar Disorders App 20100063029 - Bilbe; Graeme ; et al.	2010-03-11
BioMarkers for the Progression of Alzheimer's Disease App 20100035251 - He; Yunsheng ; et al.	2010-02-11
Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders Grant 7,638,510 - Bilbe , et al. December 29, 2	2009-12-29
Combinations of Nicotinic Acetylcholine Alpha 7 Receptor Antagonists App 20080306081 - Kalkman; Hans O. ; et al.	2008-12-11
Indolyl-pyrroledione derivatives for the treatment of neurological and vascular disorders related to beta-amyloid generation and/or aggregation App 20070142401 - Auberson; Yves ; et al.	2007-06-21
Use of pyridinyl-pyrimidinylamino-benzamide derivatives for the treatment of amyloid related disorders App 20070129389 - Bilbe; Graeme	2007-06-07
Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders App 20060194791 - Bilbe; Graeme ; et al.	2006-08-31
Genes associated with schizophrenia adhd and bipolar disorders App 20060172295 - Bilbe; Graeme ; et al.	2006-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.